Icon

NIMOTOP (nda018869)- (30MG)

NIMODIPINE BAYER PHARMS
30MG
No No
2002-Sep-27 Expired
None None
None No
NimotopĀ® (nimodipine) is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).
4 0 3
Total Other Developers None
Drugs with Suitability No
30MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********** ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ******** ****** ******** ****** **** ***. */*/* **** *************** **** ***. *********** *** ******* **, **** *********, *** ****** (**) *****, ****** ****** (***) ***
****** **************** *** ***** **** ** *********** ************ **, *********, ****, *********** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.